Literature DB >> 35895005

Application of longitudinal item response theory models to modeling Parkinson's disease progression.

Haotian Zou1, Varun Aggarwal2, Glenn T Stebbins3, Martijn L T M Müller2, Jesse M Cedarbaum4, Anne Pedata2, Diane Stephenson2, Tanya Simuni5, Sheng Luo6.   

Abstract

The Movement Disorder Society revised version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) parts 2 and 3 reflect patient-reported functional impact and clinician-reported severity of motor signs of Parkinson's disease (PD), respectively. Total scores are common clinical outcomes but may obscure important time-based changes in items. We aim to analyze longitudinal disease progression based on MDS-UPRDS parts 2 and 3 item-level responses over time and as functions of Hoehn & Yahr (H&Y) stages 1 and 2 for subjects with early PD. The longitudinal item response theory (IRT) modeling is a novel statistical method addressing limitations in traditional linear regression approaches, such as ignoring varying item sensitivities and the sum score balancing out improvements and declines. We utilized a harmonized dataset consisting of six studies with 3573 subjects with early PD and 14,904 visits, and mean follow-up time of 2.5 years (±1.57). We applied both a unidimensional (each part separately) and multidimensional (both parts combined) longitudinal IRT models. We assessed the progression rates for both parts, anchored to baseline H&Y stages 1 and 2. Both the uni- and multidimensional longitudinal IRT models indicate significant worsening time effects in both parts 2 and 3. Baseline H&Y stage 2 was associated with significantly higher baseline severities, but slower progression rates in both parts, as compared with stage 1. Patients with baseline H&Y stage 1 demonstrated slower progression in part 2 severity compared to part 3, whereas patients with baseline H&Y stage 2 progressed faster in part 2 than part 3. The multidimensional model had a superior fit compared to the unidimensional models and it had excellent model performance.
© 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2022        PMID: 35895005      PMCID: PMC9574723          DOI: 10.1002/psp4.12853

Source DB:  PubMed          Journal:  CPT Pharmacometrics Syst Pharmacol        ISSN: 2163-8306


  32 in total

1.  Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.

Authors:  A M Novakovic; E H J Krekels; A Munafo; S Ueckert; M O Karlsson
Journal:  AAPS J       Date:  2016-09-15       Impact factor: 4.009

2.  Modeling a Composite Score in Parkinson's Disease Using Item Response Theory.

Authors:  Gopichand Gottipati; Mats O Karlsson; Elodie L Plan
Journal:  AAPS J       Date:  2017-02-28       Impact factor: 4.009

3.  Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients.

Authors:  Simon Buatois; Sylvie Retout; Nicolas Frey; Sebastian Ueckert
Journal:  Pharm Res       Date:  2017-07-10       Impact factor: 4.200

4.  Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency.

Authors:  Yucheng Sheng; Xuan Zhou; Shuying Yang; Peiming Ma; Chao Chen
Journal:  Br J Clin Pharmacol       Date:  2021-02-12       Impact factor: 4.335

5.  Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.

Authors: 
Journal:  Ann Intern Med       Date:  2020-03-31       Impact factor: 25.391

6.  Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial.

Authors:  Ai Huey Tan; Shen-Yang Lim; Sanjiv Mahadeva; Mun Fai Loke; Jiun Yan Tan; Ban Hong Ang; Kok Ping Chin; Amni Fatihah Mohammad Adnan; Shawna Mei Chien Ong; Aimi Izzah Ibrahim; Nusyaibah Zulkifli; Jing Kun Lee; Wan Ting Lim; Yong Teck Teo; Yong Leng Kok; Tze Ying Ng; Aaron Guan Siang Tan; Intan Maisara Zulkifle; Chin Khoon Ng; Soon Sean Ee; Shuhaina Arafin; Khairunnisa Mohamad Shukori; Jamunarani S Vadivelu; Connie Marras; Susan H Fox; Anthony E Lang
Journal:  Mov Disord       Date:  2020-09-07       Impact factor: 10.338

7.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

8.  Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study.

Authors:  Alison J Yarnall; David P Breen; Gordon W Duncan; Tien K Khoo; Shirley Y Coleman; Michael J Firbank; Cristina Nombela; Sophie Winder-Rhodes; Jonathan R Evans; James B Rowe; Brit Mollenhauer; Niels Kruse; Gavin Hudson; Patrick F Chinnery; John T O'Brien; Trevor W Robbins; Keith Wesnes; David J Brooks; Roger A Barker; David J Burn
Journal:  Neurology       Date:  2013-12-20       Impact factor: 9.910

9.  Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease.

Authors:  Raúl Martínez-Fernández; Jorge U Máñez-Miró; Rafael Rodríguez-Rojas; Marta Del Álamo; Binit B Shah; Frida Hernández-Fernández; José A Pineda-Pardo; Mariana H G Monje; Beatriz Fernández-Rodríguez; Scott A Sperling; David Mata-Marín; Pasqualina Guida; Fernando Alonso-Frech; Ignacio Obeso; Carmen Gasca-Salas; Lydia Vela-Desojo; W Jeffrey Elias; José A Obeso
Journal:  N Engl J Med       Date:  2020-12-24       Impact factor: 91.245

10.  Help cure Parkinson's disease: please don't waste the Golden Year.

Authors:  Robert A Hauser
Journal:  NPJ Parkinsons Dis       Date:  2018-09-25
View more
  1 in total

1.  Application of longitudinal item response theory models to modeling Parkinson's disease progression.

Authors:  Haotian Zou; Varun Aggarwal; Glenn T Stebbins; Martijn L T M Müller; Jesse M Cedarbaum; Anne Pedata; Diane Stephenson; Tanya Simuni; Sheng Luo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.